The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ECHO THERAPEUTICS INC | COM NEW | 27876l206 | 1,285 | 829,183 | SH | OTR | 829,183 | 0 | 0 | ||
| INSPIREMD INC | COM NEW | 45779A309 | 9 | 5,692 | SH | OTR | 5,692 | 0 | 0 | ||
| NAVIDEA BIOPHARMACEUTICALS I | COM | 63937X103 | 28,970 | 12,706,324 | SH | OTR | 12,706,324 | 0 | 0 | ||
| PEDEVCO CORP | COM NEW | 70532Y204 | 852 | 3,409,444 | SH | OTR | 3,409,444 | 0 | 0 | ||
| YOU ON DEMAND | COM NEW | 98741R | 6 | 3,015 | SH | OTR | 3,015 | 0 | 0 | ||